Apollo Global Management LLC Class A (APO)vsBlackRock Health Sciences Trust II (BMEZ)
APO
Apollo Global Management LLC Class A
$125.91
-0.07%
FINANCIAL SERVICES · Cap: $83.12B
BMEZ
BlackRock Health Sciences Trust II
$16.50
-0.30%
FINANCIAL SERVICES · Cap: $1.03B
Smart Verdict
WallStSmart Research — data-driven comparison
APO leads profitability with a 5.3% profit margin vs 0.0%. BMEZ trades at a lower P/E of 4.8x. APO earns a higher WallStSmart Score of 72/100 (B).
APO
Strong Buy72
out of 100
Grade: B
BMEZ
Avoid32
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 63.8% year-over-year
Earnings expanding 63.7% YoY
Large-cap with strong market position
Growing faster than its price suggests
Strong operational efficiency at 22.0%
Generating 3.2B in free cash flow
Attractively priced relative to earnings
Conservative balance sheet, low leverage
Areas to Watch
5.3% margin — thin
Weak financial health signals
Premium valuation, high expectations priced in
Distress zone — elevated risk
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 5.7% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : APO
The strongest argument for APO centers on Revenue Growth, EPS Growth, Market Cap. Revenue growth of 63.8% demonstrates continued momentum. PEG of 0.65 suggests the stock is reasonably priced for its growth.
Bull Case : BMEZ
The strongest argument for BMEZ centers on P/E Ratio, Debt/Equity.
Bear Case : APO
The primary concerns for APO are Profit Margin, Piotroski F-Score, P/E Ratio. A P/E of 49.9x leaves little room for execution misses.
Bear Case : BMEZ
The primary concerns for BMEZ are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
APO profiles as a hypergrowth stock while BMEZ is a value play — different risk/reward profiles.
APO is growing revenue faster at 63.8% — sustainability is the question.
APO generates stronger free cash flow (3.2B), providing more financial flexibility.
Monitor ASSET MANAGEMENT industry trends, competitive dynamics, and regulatory changes.
Bottom Line
APO scores higher overall (72/100 vs 32/100) and 63.8% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Apollo Global Management LLC Class A
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Apollo Global Management LLC Class A (APO) is a prominent global alternative investment firm that specializes in private equity, credit, and real estate investments across various sectors, including healthcare, financial services, and technology. With a rigorous, research-driven investment strategy and significant industry expertise, Apollo identifies and capitalizes on high-potential opportunities in both developed and emerging markets. The firm is dedicated to maximizing portfolio performance and driving sustainable growth, seeking to deliver attractive risk-adjusted returns for its investors. With a strong capital base and a proven track record, Apollo Global Management stands as a leader in the alternative investment landscape.
BlackRock Health Sciences Trust II
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
BlackRock Health Sciences Trust II (BMEZ) is a closed-end fund that focuses on delivering high total returns through a diversified portfolio primarily concentrated in the health sciences sector, which encompasses pharmaceuticals, biotechnology, and medical devices. Capitalizing on BlackRock's extensive industry knowledge, BMEZ targets significant growth opportunities driven by demographic shifts and increasing healthcare spending. With its disciplined investment approach and commitment to funding innovative healthcare solutions, BMEZ provides institutional investors a compelling avenue for portfolio enhancement in a dynamic and rapidly evolving market landscape.
Compare with Other ASSET MANAGEMENT Stocks
Want to dig deeper into these stocks?